К ВОПРОСУ О МЕХАНИЗМАХ РАЗВИТИЯ ТАХИ-ИНДУЦИРОВАННОЙ КАРДИОМИОПАТИИ У ПАЦИЕНТОВ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ
Аннотация
В статье приведены современные данные о причинах и механизмах развития тахи-индуцированной кардиомиопатии, отражены основные стратегии лечения. При анализе литературы выявлено, что в настоящее время не разработаны единые критерии дифференциальной диагностики, недостаточно изучена роль генетической предрасположенности и воспалительного процесса в этиопатогенезе данной патологии.
Литература
Вайханская, Т. Г. Тахииндуцированная кардиомиопатия. Разрешима ли загадка о курице и яйце? / Т. Г. Вайханская, И. В. Сидоренко, А. А. Макеева, Т. В. Курушко // Кардиология в Беларуси. – 2013. – № 3. – С. 83 – 102.
Мазур, Н. А. Фибрилляция предсердий / Н. А. Мазур // Клиническая фармакология и терапия. – 2003. – № 3. – С. 32–35.
Насонов, Е. Л. Иммунопатология застойной сердечной недостаточности: роль цитокинов / Е. Л. Насонов, М. Ю. Самсонов, Ю. Н. Беленков // Кардиология. – 1999. – № 3. – С. 66–73.
Снежицкий, В. А. Феномен электрофизиологического ремоделирования предсердий и синусового узла: механизмы развития и патогенез / В. А. Снежицкий // Клиническая медицина. – 2004. – № 11. – С. 10–14.
Снежицкий, В. А. Фибрилляция предсердий. Особенности регуляции ритма сердца и транспорта кислорода кровью / В. А .Снежицкий, Е. С. Пелеса, М. С. Дешко. – LAP Lambert Academic Publishing. – 2013. – 107 с.
Татарский, Б. А. Сердечная недостаточность и фибрилляция предсердий: особенности предсердного ремоделирования / Б. А. Татарский, Г. П. Арутюнов // Сердечная недостаточность. – 2011. – Т. 12, № 5 (67). – С. 302–308.
Хронотропная функция сердца : монография / В. А. Снежицкий [и др.] ; под ред. В. А. Снежицкого. – Гродно: ГрГМУ, 2011. – 232 с.
Aviles, R. J. Inflammation as a risk factor foratrialfibrillation / R. J. Aviles [et al.] // Circulation. – 2003. – Vol. 108. – P. 3006–3010.
Burzotta, F. Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization / F. Burzotta[et al.] // Am. J. Cardiol. – 2001. – Vol. 88. – P. 1125 – 1128.
Byrne, M. J. An ovine model of tachycardia-induced degenerative dilatedcardiomyopathy and heart failure with prolonged onset / M. J. Byrne [et al.] // J. Card.Fail. – 2002. – Vol.8. – P.108 – 115.
Calo, L. Tachycardia-induced cardiomyopathy: mechanisms of heart failure and clinical implications / L. Calo, E. De Ruvo, A. Sette [et al.] // J. Cardiovasc. Med. – 2007. – Vol.8. – P.138–143.
Chin, A. The clinical, electrocardiographic and echocardiographic characteristics and long-term outcome of patients with tachycardia-induced cardiomyopathy / A.Chin [et al.] // Cardiovascular Journal of Africa. – 2012. – Vol. 23, № 3 – P.136 – 142.
Clinical Characteristics, Treatment, and Outcome of Tachycardia Induced Cardiomyopathy / H. Watanabe[et al.] // Int. Heart J. – 2008. – Vol. 49, № 1. – P. 39 – 46.
C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation / M. K. Chung [et al.] // Circulation. – 2001. – Vol. 104. – P. 2886 – 2891.
Deshmukh, P. M. Association of angiotensin converting enzyme gene polymorphism with tachycardia cardiomyopathy / P. M. Deshmukh [et al.] // Int. J. Mol. Med. – 2004. – Vol.13. – P. 455 – 458.
Gentlesk, P. J Reversal of left ventricular dysfunction following ablation of atrial fibrillation / P. J. Gentlesk [et al.] // J. Cardiovasc. Electrophysiol. – 2007. – Vol. 18. – P. 9-14.
Gossage, A. M. On auricular fibrillation / A. M. Gossage, J. A. Braxton Hicks // Q. J. Med. – 1913. – Vol. 6. – P. 435–340.
Grogan, M. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy / M. Grogan [et al.] // Am. J. Cardiol. – 1992. – Vol. 69. – P. 1570.
Heinz, G. Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter / G. Heinz // Am. J. Cardiol. – 1992. – Vol. 69. – P. 489–492
Hsu, L. F. Catheter ablation for atrial fibrillation in congestive heart failure / L. F. Hsu [et al.] // N. Engl. J. Med. – 2004. – Vol. 351. – P. 2373 – 2383.
Jeong, Y. H Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy / Y. H. Jeong [et al.] // Clin. Cardiol. – 2008. – Vol. 31. – P. 172–178.
Kajstura, J. The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy / J. Kajstura [et al.] // Circulation. – 1995. – Vol. 92. – P. 2306 – 2317.
Khan, M. N Pulmonary-vein isolation for atrial fi brillation in patients with heart failure / M. N. Khan, P. Jais, J.Cummings // N. Engl. J. Med. – 2008. Vol. 359. – P. 1778 – 1785.
Khasnis, A. Tachycardiainduced cardiomyopathy: a review of literature / A. Khasnis, K. Jongnarangsin, G. Abela[et al.] // Pacing and Clinical Electrophysiology. – 2005. – Vol. 28. – P. 710–721.
Malcom, J. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure – 2008 update: Best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies / J. Malcom [et al.] // Can. J. Cardiol. – 2008. – Vol. 24. – P. 21-40.
Manolis, A. G. Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias / A. G. Manolis [et al.] // J. Interv. Card. Electrophysiol. – 1998. – Vol. 2. – P. 71-76.
Medi, C. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia / C. Medi[et al.] // J. Am. Coll. Cardiol. – 2009. – Vol. 53. – P. 1791–1797.
Nakai, K. Deletion polymorphism of the angiotensin-I converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the elderly / K. Nakai, C. Itoh, Y. Miura // Circulation. – 1994. – Vol. 90. – P. 2199 –2202.
Nattel, S. Atrial electrophysiology and mechanisms of atrial fibrillation / S.Nattel // J. Cardiovasc.Pharmacol. Therapeutics. – 2003. –Vol. 8, № 1. – P. 5–11.
Nerheim, P. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia / P. Nerheim[et al.] // Circulation. – 2004. – Vol. 110. – P. 247-252.
Neuberg, H. R. Atrial remodeling in the goat to chronic complete atrioventricular block / H. R. Neuberg, U. Schotten, J. Ausma[et al.] // Eur. Heart J. – 2002. – Vol. 22. – P. 138-142.
O’Brien, P. J. Myocardial sarcoplasmic reticulum function in the development and recovery from heart failure / P. J. O’Brien [et al.] // J. Am. Coll. Cardiol. – 1993. - Vol. 21. – P. 255A
O’Brien, P. J. Rapid ventricular pacing of dogs to heart failure: biochemical and physiological studies / P. J. O’Brien [et al.] // Can. J. Physiol. Pharmacol. – 1990. – Vol. 68. – P. 34-39.
Perreault, C. L. Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure / C. L. Perreault [et al.] // J. Clin. Invest. – 1992. – Vol. 89. – P. 932–938.
Persistent left ventricular dilatation in tachycardia- induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction / G. Dandamudi [et al.] // Heart Rhythm. – 2008. – Vol. 5(8) – P. 1111-1115.
Pizzale, S. Frequency and predictors of tachycardia-induced cardiomyopathy in patients with persistent atrial flutter / S. Pizzale [et al.] // Can. J. Cardiol. – 2009. – Vol. 25, № 8. – P. 469–472.
Qin, F. Selegiline attenuates cardiac oxidative stress and apoptosis in heart failure: Association with improvement of cardiac function / F. Qin [et al.] // Eur. J. Pharmacol. – 2003. – Vol. 461(2-3). – P. 149–158.
Redfield, MM. Tachycardiarelated cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation / MM. Redfield [et al.] // Mayo Clin. Proc. – 2000. – Vol. 75. – P. 790–795.
Saavedra,W. F. Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure / W. F. Saavedra [et al.] // J. Am. Coll. Cardiol. – 2002. – Vol. 39. – P. 2069–2076.
Shinbane, J. S. Tachycardiainduced cardiomyopathy: a review of animal models and clinical studies / J. S. Shinbane, M. Wood, D. N. Jensen // J Am Coll Cardiol. – 1997. – Vol. 29. – P. 709–715.
Spinale, F. G. Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia / F. G. Spinale [et al.] // Am. J. Physiol. – 1991. – Vol. 261. – P. 308–318.
Spinale, F. G. Myocardial Na(+), K(+)-ATPase in tachycardia induced cardiomyopathy / F. G. Spinale [et al.] // J Mol. Cell. Cardiol. – 1992. – Vol. 24. – P. 227-294.
Spinale, F. G. Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy / F. G. Spinale [et al.] // Circ. Res. – 1991. – Vol. 69. – P. 1058-1067.
Tachycardia–induced Cardiomyopathy (Tachycardio- myopathy) / Hassan A Mohamed // Libyan J. Med. – 2007. – Vol. 2. – P. 26–29.
Takahashi , M. Role of microtubules in the contractile dysfunction of myocytes from tachycardia-induced dilated cardiomyopathy / M. Takahashi [et al.] // J Mol. Cell. Cardiol. – 1998. – Vol. 30. – P. 1047-1057.
Whipple, G. H. Reversible congestive heart failure due to chronic rapid stimulation of the normal heart / G. H. Whipple [et al.] // Pro. N. Engl. Cardiovasc. Soc. – 1962. – Vol. 20. – P. 39–40.
Wilson, J. R. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects / J. R. Wilson [et al.] // Circulation. – 1987. – Vol. 75, № 4. – P. 857-867.
Wolff, M. R. Calcium sensitivity of isometric tension is increased in canine experimental heart failure / M. R. Wolff [et al.] // Circ. Res. – 1995. – Vol. 76. – P. 781-789.
